Arkolith/Insider Trading/CADL/Form 4

Manning Paul B

DirectorCandel Therapeutics, Inc. (CADL) · full profile →Form 4 · filed Dec 18, 2024
Net Buying
Open-Market Buys
$7.5M
Open-Market Sells
$0
Net Open-Market Flow
$7.5M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 16, 2024Buy(P)500K$6.00$3.0M1.1M
Dec 16, 2024Buy(P)750K$6.00$4.5M1.3M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-137889) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML